Autism spectrum disorders (ASDs) are characterized by impaired language and social skills, often with restricted interests and stereotyped behaviors. A previous investigation of blood plasma from children with ASDs (mean age = 5½ years) demonstrated that 21% of samples contained autoantibodies that reacted intensely with GABAergic Golgi neurons of the cerebellum while no samples from non-sibling, typically developing children showed similar staining (Wills et al., 2009). In order to characterize the clinical features of children positive for these autoantibodies, we analyzed plasma samples from children enrolled in the Autism Phenome Project, a multidisciplinary project aimed at identifying subtypes of ASD. Plasma from male and female children (mean age = 3.2 years) was analyzed immunohistochemically for the presence of autoantibodies using histological sections of macaque monkey brain. Immunoreactivity to cerebellar Golgi neurons and other presumed interneurons was observed for some samples but there was no difference in the rate of occurrence of these autoantibodies between children with ASD and their typically developing peers. Staining of neurons, punctate profiles in the molecular layer of the dentate gyrus, and neuronal nuclei were also observed. Taken together, 42% of controls and subjects with ASD demonstrated immunoreactivity to some neural element. Interestingly, children whose plasma reacted to brain tissue had scores on the Child Behavior Checklist (CBCL) that indicated increased behavioral and emotional problems. Children whose plasma was immunoreactive with neuronal cell bodies scored higher on multiple CBCL scales. These studies indicate that additional research into the genesis and prevalence of brain-directed autoantibodies is warranted.
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Introduction
Autism spectrum disorders (ASDs) are characterized by impaired social functioning and language development combined with a restricted or stereotyped set of behaviors that emerge by three years of age. The most recent estimate of their prevalence indicates that one in 110 children in the United States is diagnosed with an ASD (2009). Males are affected about four times more frequently than females (Fombonne, 2005) . Higher concordance rates for these disorders in monozygotic twins compared to dizygotic twins suggest that ASDs are highly heritable (Bailey et al., 1995) , and multiple different genetic variations are known to be associated with ASDs (Folstein and Rosen-Sheidley, 2001 ). Currently, 10-20% of cases are associated with defined mutations, genetic syndromes, or de novo copy number variations, and further cases will likely be attributable to genetic variations upon further study (Abrahams and Geschwind, 2008) . However, none of the variations discovered so far consistently results in an individual developing an ASD, suggesting other factors must be involved (Abrahams and Geschwind, 2008) .
Numerous studies have identified abnormalities in the immune systems of some individuals with an ASD (Ashwood et al., 2006; Pardo et al., 2005) . Postmortem studies point to increased microglial activation in the cerebellum, cortex, and white matter of some individuals with ASD compared to typically developing controls (Morgan et al., 2010; Vargas et al., 2005) . Brain tissue and cerebrospinal fluid of children and adults with autism display an increased level of the cytokines macrophage chemoattractant protein-1, tumor growth factor-b1, tumor necrosis factor a, interleukin-6, granulocyte-macrophage colony-stimulating factor, and interferon c (Li et al., 2009; Vargas et al., 2005) . In a study involving 80 subjects with ASD, a screen for anti-nuclear antibodies in serum found that more children with autism possess anti-nuclear antibodies than
